Vitiligo: analysis of grafting versus curettage alone, using melanocyte morphology and reverse transcriptase polymerase chain reaction for tyrosinase mRNA
- PMID: 16389417
- PMCID: PMC11060411
- DOI: 10.1590/s1516-31802005000400006
Vitiligo: analysis of grafting versus curettage alone, using melanocyte morphology and reverse transcriptase polymerase chain reaction for tyrosinase mRNA
Abstract
Context and objective: Recent studies have indicated that vitiligo areas contain inactive or dormant melanocytes. Melanin synthesis is related to tyrosinase presence and indicative of active metabolic state. The aim of this study was to compare repigmentation, epidermal melanocyte distribution and tyrosinase mRNA detection through reverse transcriptase polymerase chain reaction, in tissue samples of vitiligo, before and after curettage, with or without subsequent autologous skin graft using a new method.
Design and setting: Prospective, in the Department of Dermatology, Faculdade de Medicina do ABC, Santo André.
Methods: Two vitiligo areas were curetted. One subsequently received grafted normal sacral autologous skin, whereas the other had no further treatment. The curetted areas were examined after 30 days, to evaluate the degree of repigmentation. The melanocyte percentages and tyrosinase mRNA presence in normal skin and vitiligo areas, before and after curettage and grafting, were compared.
Results: Complete repigmentation was seen in all grafted areas, whereas non-grafted curetted vitiligo presented partial repigmentation. The melanocyte percentage in grafted areas was greater than in non-treated vitiligo skin (p = 0.01) and skin with curettage alone (p = 0.015). Tyrosinase mRNA was negative in 93.75% of non-treated vitiligo areas. After treatment (curettage alone or curettage and grafting), all lesions became positive for tyrosinase mRNA.
Conclusion: Metabolically inactive or dormant melanocytes are probably present within vitiligo areas, and may be activated by exogenous or endogenous stimuli.
CONTEXTO E OBJETIVO:: Estudos recentes têm indicado que áreas de vitiligo contêm melanócitos inativos ou dormentes. A síntese de melanina está relacionada com a presença de tirosinase é indicadora de estado metabólico ativo. O escopo deste artigo é comparar repigmentação, distribuição epidérmica de melanócitos e detecção do RNAm de tirosinase através da reação de polimerase em cadeia por transcriptase reversa, em amostras de tecido de vitiligo, antes e após curetagem, seguido ou não por uma nova técnica de enxerto autólogo de pele.
TIPO DE ESTUDO E LOCAL:: Prospectivo, na Disciplina de Dermatologia da Faculdade de Medicina do ABC, Santo André.
MÉTODOS:: Duas áreas de vitiligo foram curetadas. Uma foi subseqüentemente enxertada com pele autóloga sacral normal, enquanto a outra não recebeu nenhum enxerto. As áreas curetadas foram examinadas após 30 dias, para avaliar o grau de repigmentação. A porcentagem de melanócitos e a presença de RNAm de tirosinase de pele normal e de pele de vitiligo (antes e após curetagem apenas e antes e após curetagem seguida de enxertia) foram comparadas.
RESULTADOS:: Repigmentação completa foi observada em todas as áreas enxertadas, enquanto as áreas de vitiligo apenas curetadas apresentaram repigmentação parcial. A porcentagem de melanócitos nas áreas enxertadas excederam as áreas de vitiligo não tratados (p = 0.01) e as áreas tratadas com curetagem simples (p = 0,015). RNAm de tirosinase foi negativo em 93.75% das áreas não tratadas de vitiligo. Após tratamento (somente curetagem ou curetagem seguida de enxerto), todas as lesões tornaram-se positivas para RNAm de tirosinase.
CONCLUSÃO:: Melanócitos metabolicamente inativos ou dormentes estão provavelmente presentes dentro das áreas de vitiligo, e podem ser ativados por estímulos endógenos ou exógenos.
Conflict of interest statement
Figures



Similar articles
-
Epidermal curettage technique (ECT) for tissue harvest from the donor area for melanocyte autologous grafting in cases of vitiligo.An Bras Dermatol. 2014 Jul-Aug;89(4):681-3. doi: 10.1590/abd1806-4841.20142865. An Bras Dermatol. 2014. PMID: 25054767 Free PMC article.
-
Autotransplantation in vitiligo: treatment with epidermal grafts and cultured melanocytes.Acta Derm Venereol. 1993 Feb;73(1):46-8. doi: 10.2340/00015555734648. Acta Derm Venereol. 1993. PMID: 8095751
-
A new model of epidermal culture for the surgical treatment of vitiligo.Int J Dermatol. 1998 Aug;37(8):595-8. doi: 10.1046/j.1365-4362.1998.00411.x. Int J Dermatol. 1998. PMID: 9732005
-
Surgical approaches for stable vitiligo.Dermatol Surg. 2005 Oct;31(10):1277-84. doi: 10.1111/j.1524-4725.2005.31203. Dermatol Surg. 2005. PMID: 16188179 Review.
-
Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review.J Eur Acad Dermatol Venereol. 2021 May;35(5):1077-1086. doi: 10.1111/jdv.17108. Epub 2021 Feb 12. J Eur Acad Dermatol Venereol. 2021. PMID: 33428279 Free PMC article.
Cited by
-
Evaluation of serum immunoglobulins concentrations and distributions in vitiligo patients.Immunol Res. 2016 Dec;64(5-6):1150-1156. doi: 10.1007/s12026-016-8809-7. Immunol Res. 2016. PMID: 27417998
-
Non-cultured melanocyte/keratinocyte transplantation for the treatment of stable vitiligo on the face: report of two cases.An Bras Dermatol. 2013 Sep-Oct;88(5):811-3. doi: 10.1590/abd1806-4841.20132054. An Bras Dermatol. 2013. PMID: 24173191 Free PMC article.
-
Surgical Treatment of Vitiligo.Int J Environ Res Public Health. 2022 Apr 15;19(8):4812. doi: 10.3390/ijerph19084812. Int J Environ Res Public Health. 2022. PMID: 35457678 Free PMC article. Review.
-
Epidermal curettage technique (ECT) for tissue harvest from the donor area for melanocyte autologous grafting in cases of vitiligo.An Bras Dermatol. 2014 Jul-Aug;89(4):681-3. doi: 10.1590/abd1806-4841.20142865. An Bras Dermatol. 2014. PMID: 25054767 Free PMC article.
-
Notable Enhancement of Facial Scarring Following Autologous Melanocyte-Keratinocyte Transplantation and NUVB Therapy: A Case Report.J Lasers Med Sci. 2022 Dec 28;13:e78. doi: 10.34172/jlms.2022.78. eCollection 2022. J Lasers Med Sci. 2022. PMID: 37041771 Free PMC article.
References
-
- Pawelek JM. After dopachrome? Pigment Cell Res. 1991;4(2):53–62. - PubMed
-
- Breathnach AS, Bor S, Wyllie LM. Electron microscopy of peripheral nerve terminals and marginal melanocytes in vitiligo. J Invest Dermatol. 1966;47(2):125–140. - PubMed
-
- Xie Z, Chen D, Jiao D, Bystryn JC. Vitiligo antibodies are not directed to tyrosinase. Arch. Dermatol. 1999;135(4):417–422. - PubMed
-
- Okamoto T, Irie RF, Fujii S, et al. Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy. J Invest Dermatol. 1998;111(6):1034–1039. - PubMed
-
- Bartosik J, Wulf HC, Kobayasi T. Melanin and melanosome complexes in long standing stable vitiligo - an ultrastructural study. Eur J Dermat. 1998;8(2):95–97. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical